Forty-four-day-old Emirati Infant Battling SMA 1 Receives Life-Saving Treatment with Zolgensma Early detection and swift collaboration between multiple stakeholders have resulted in the baby receiving timely treatment. Abu Dhabi: A 44-day-old infant, diagnosed with the rare genetic disease Spinal Muscular Atrophy type 1 (SMA 1), has received the Zolgensma injection, a pioneering medicine used to … Continue reading Forty-four-day-old Emirati Infant Battling SMA 1 Receives Life-Saving Treatment with Zolgensma